1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Pneumococcal Testing Market, by Method
6.1. Introduction
6.2. Immunodiagnostics
6.3. Molecular Diagnostic
6.4. Point of Care Testing

7. Pneumococcal Testing Market, by Technology
7.1. Introduction
7.2. Enzyme Linked Immunosorbent Assay
7.3. Immunofluorescence
7.4. Immunohistochemistry
7.5. Nucleic Acid Sequence based Amplification
7.6. Polymerase Chain Reaction
7.7. Western Blot Test

8. Pneumococcal Testing Market, by Product Type
8.1. Introduction
8.2. Analyzers
8.3. Consumables

9. Pneumococcal Testing Market, by End-user
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals and Clinics

10. California Pneumococcal Testing Market

11. Florida Pneumococcal Testing Market

12. Illinois Pneumococcal Testing Market

13. New York Pneumococcal Testing Market

14. Ohio Pneumococcal Testing Market

15. Pennsylvania Pneumococcal Testing Market

16. Texas Pneumococcal Testing Market

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Abbott Laboratories
18.2. ACON LABS INC.
18.3. Agilent Technologies, Inc
18.4. BECKMAN COULTER, INC.
18.5. Becton, Dickinson and Company
18.6. Bio-Rad Laboratories, Inc.
18.7. bioMérieux S.A.
18.8. Cepheid Inc.
18.9. F-Hoffmann la Roche Ltd.
18.10. Hologic, Inc.
18.11. Karger AG
18.12. Merck KGaA
18.13. MERIDIAN BIOSCIENCE, INC.
18.14. Novartis AG
18.15. Pfizer Inc.
18.16. Portea Medical
18.17. Qiagen N.V.
18.18. Quest Diagnostics Incorporated
18.19. Rite Aid Corp
18.20. Syngene International Ltd
18.21. Thermo Fisher Scientific Inc.
18.22. Trinity Biotech PLC

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES PNEUMOCOCCAL TESTING MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES PNEUMOCOCCAL TESTING MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2027
FIGURE 6. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTIC, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (%)
FIGURE 13. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 15. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY WESTERN BLOT TEST, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY WESTERN BLOT TEST, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2027 (%)
FIGURE 28. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2027
FIGURE 30. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY ANALYZERS, 2018-2027 (USD MILLION)
FIGURE 31. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY ANALYZERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 32. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2027 (USD MILLION)
FIGURE 33. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY CONSUMABLES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2020 VS 2027 (%)
FIGURE 35. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2020 VS 2027 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2027
FIGURE 37. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2027 (USD MILLION)
FIGURE 38. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 39. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2027 (USD MILLION)
FIGURE 40. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 41. UNITED STATES PNEUMOCOCCAL TESTING MARKET: FPNV POSITIONING MATRIX
FIGURE 42. UNITED STATES PNEUMOCOCCAL TESTING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 43. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES PNEUMOCOCCAL TESTING MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES PNEUMOCOCCAL TESTING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTIC, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY WESTERN BLOT TEST, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY ANALYZERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY CONSUMABLES, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES PNEUMOCOCCAL TESTING MARKET: SCORES
TABLE 21. UNITED STATES PNEUMOCOCCAL TESTING MARKET: BUSINESS STRATEGY
TABLE 22. UNITED STATES PNEUMOCOCCAL TESTING MARKET: PRODUCT SATISFACTION
TABLE 23. UNITED STATES PNEUMOCOCCAL TESTING MARKET: RANKING
TABLE 24. UNITED STATES PNEUMOCOCCAL TESTING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 25. UNITED STATES PNEUMOCOCCAL TESTING MARKET: MERGER & ACQUISITION
TABLE 26. UNITED STATES PNEUMOCOCCAL TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 27. UNITED STATES PNEUMOCOCCAL TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 28. UNITED STATES PNEUMOCOCCAL TESTING MARKET: INVESTMENT & FUNDING
TABLE 29. UNITED STATES PNEUMOCOCCAL TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 30. UNITED STATES PNEUMOCOCCAL TESTING MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
ACON LABS INC.
Agilent Technologies, Inc
BECKMAN COULTER, INC.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
bioMérieux S.A.
Cepheid Inc.
F-Hoffmann la Roche Ltd.
Hologic, Inc.
Karger AG
Merck KGaA
MERIDIAN BIOSCIENCE, INC.
Novartis AG
Pfizer Inc.
Portea Medical
Qiagen N.V.
Quest Diagnostics Incorporated
Rite Aid Corp
Syngene International Ltd
Thermo Fisher Scientific Inc.
Trinity Biotech PLC